Skip to content
MedsAcross

Fixed-dose combination

Fluocinolone acetonide and Neomycin

Also known as fluocinolone acetonide, neomycin sulfate
Available on request
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Fluocinolone acetonide and Neomycin is a fixed-dose combination of an aminoglycoside antibacterial and a corticosteroid indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. It is available as cream for topical use. MedsAcross supplies Fluocinolone acetonide and Neomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Aminoglycoside Antibacterial, Corticosteroid, Corticosteroid Hormone Receptor Agonists
US FDA first approval
Approved
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical
Dosage forms
Cream
Fixed-dose combination of
Fluocinolone acetonide, Neomycin

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

NEO-SYNALAR ® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. It has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment.

Source: US FDA prescribing information

Dosing overview

NEO-SYNALAR ® cream is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Since NEO-SYNALAR ® cream is a water-washable vanishing cream, it is easily applied and leaves no traces.

Source: US FDA prescribing information

Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. This product should not be used in the external auditory canal if the eardrum is perforated.

Source: US FDA prescribing information

Warnings and precautions

If local infection should continue or become severe, or in the presence of systemic infection, appropriate systemic antibacterial therapy, based on susceptibility testing, should be considered. Because of the concern of nephrotoxicity and ototoxicity associated with neomycin, this combination product should not be used over a wide area or for extended periods of time. There are articles in the current medical literature that indicate an increase in the prevalence of persons sensitive to neomycin.

Source: US FDA prescribing information

Side effects

The following local adverse reactions are reported infrequently with topical corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermatitis Miliaria The following adverse reactions have been reported with the topical use of neomycin: Ototoxicity Nephrotoxicity

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Fluocinolone acetonide and Neomycin, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Neo-Synalar 0.25 mg/3.5 mg per g creamTopicalFluocinolone acetonide and NeomycinEurofarmaUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAApprovedDrugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Fluocinolone acetonide and Neomycin available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Fluocinolone acetonide and Neomycin and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Fluocinolone acetonide and Neomycin have?

The catalogue lists 1 brand names for Fluocinolone acetonide and Neomycin, including Neo-Synalar.

Does Fluocinolone acetonide and Neomycin need cold chain shipping?

No listed presentation of Fluocinolone acetonide and Neomycin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Neo-Synalar prescribing information (Eurofarma). U.S. National Library of Medicine, DailyMed. Retrieved 18 March 2026

Request Fluocinolone acetonide and Neomycin for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.